Partnership enters its ninth year after training over 2,200 young people and enabling employment for more than 1,750 beneficiaries through nursing assistant and digital skills programs
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
LYMPHIR addresses a clear clinical need in a disease with limited treatment options
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
The full approval is based on the results from the pivotal Phase 3 EPCORE FL-1 study
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
Subscribe To Our Newsletter & Stay Updated
